Literature DB >> 7664547

Noninvasive monitoring of cardiac output by Doppler echocardiography in patients treated with volume expansion after subarachnoid hemorrhage.

S A Mayer1, D Sherman, M E Fink, S Homma, R A Solomon, L Lennihan, A Beckford, L M Klebanoff.   

Abstract

OBJECTIVE: To assess the validity and potential clinical utility of cardiac output monitoring using Doppler echocardiography in patients treated with volume expansion after subarachnoid hemorrhage.
DESIGN: Observational study of patients in a randomized, clinical trial.
SETTING: Neurologic intensive care unit. PATIENTS: Simultaneous, blinded measurements of cardiac output by thermodilution and Doppler echocardiography were performed in 48 patients 1 or 2 days after aneurysmal clipping. Follow-up Doppler echocardiography was performed an average of 3.9 days later (range 3 to 6) in 15 patients assigned to normovolemia and 24 patients assigned to hypervolemia. INTERVENTION: Patients received supplemental 5% albumin in order to maintain increased (hypervolemia) or normal (normovolemia) cardiac filling pressures.
MEASUREMENTS AND MAIN RESULTS: The overall degree of correlation between the two measures was moderate (r = .67, r2 = .45, p < .0001). Bias and precision calculations (-0.75 +/- 1.34 L/min) showed a tendency for Doppler echocardiography to underestimate thermodilution, particularly when cardiac output was very high. Although hypervolemia patients received more 5% albumin than normovolemia patients, mean percent change in Doppler echocardiography cardiac output did not differ between the two groups. Multiple regression analysis showed that the percent change in Doppler echocardiography cardiac output correlated strongly with changes in heart rate (p < .0001), but not with daily net fluid balance or 5% albumin administration.
CONCLUSIONS: Agreement was poor between Doppler echocardiography and thermodilution measurements of cardiac output, and trends reflected variations in heart rate rather than fluid status. Monitoring of cardiac output by this technique cannot be recommended in patients treated with volume expansion after subarachnoid hemorrhage.

Entities:  

Mesh:

Year:  1995        PMID: 7664547     DOI: 10.1097/00003246-199509000-00005

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  6 in total

Review 1.  Systematic review of cardiac output measurements by echocardiography vs. thermodilution: the techniques are not interchangeable.

Authors:  Mik Wetterslev; Hasse Møller-Sørensen; Rasmus Rothmann Johansen; Anders Perner
Journal:  Intensive Care Med       Date:  2016-03-01       Impact factor: 17.440

Review 2.  Advanced monitoring of systemic hemodynamics in critically ill patients with acute brain injury.

Authors:  Fabio Silvio Taccone; Giuseppe Citerio
Journal:  Neurocrit Care       Date:  2014-12       Impact factor: 3.210

3.  Cardiac complications in acute ischemic stroke.

Authors:  Charles R Wira; Emanuel Rivers; Cynthia Martinez-Capolino; Brian Silver; Gayathri Iyer; Robert Sherwin; Christopher Lewandowski
Journal:  West J Emerg Med       Date:  2011-11

4.  B-type natriuretic peptide release and left ventricular filling pressure assessed by echocardiographic study after subarachnoid hemorrhage: a prospective study in non-cardiac patients.

Authors:  Eric Meaudre; Christophe Jego; Nadia Kenane; Ambroise Montcriol; Henry Boret; Philippe Goutorbe; Gilbert Habib; Bruno Palmier
Journal:  Crit Care       Date:  2009-05-20       Impact factor: 9.097

5.  Cardiac output measurements via echocardiography versus thermodilution: A systematic review and meta-analysis.

Authors:  Yun Zhang; Yan Wang; Jing Shi; Zhiqiang Hua; Jinyu Xu
Journal:  PLoS One       Date:  2019-10-03       Impact factor: 3.240

6.  Cardiac output measured by transthoracic echocardiography and Swan-Ganz catheter. A comparative study in mechanically ventilated patients with high positive end-expiratory pressure.

Authors:  José Gorrasi; Arturo Pazos; Lucia Florio; Carlos Américo; Natalia Lluberas; Gabriel Parma; Ricardo Lluberas
Journal:  Rev Bras Ter Intensiva       Date:  2019 Oct-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.